Smart Biomolecules, Inc.

Biotech · Private

Small molecule therapeutic (THPI-244 and analogs) that increases soluble APPα to treat Alzheimer's disease

Grants
$525K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Novel piperazine tethered thiazole compounds as antimalarials$225,000
Federal grantDepartment of Health and Human Services · Phase I · Identification of Small Molecule Amyloid Beta Peptide Reducing Agent$300,001
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3162PACDNA LLC——
3163ANTEL BIOSYSTEMS, INC——
3164TORRALVA MEDICAL THERAPUETICS LLC——
3165Smart Biomolecules, Inc.——
3166IONIC PHARMACEUTICALS, LLC——
3167Sitryx Therapeutics——
3168SCHEDULE 1 THERAPEUTICS INC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.